Literature DB >> 15269630

Development of Crohn disease during anti-TNF-alpha therapy in a child with juvenile idiopathic arthritis.

F M Ruemmele1, A-M Prieur, C Talbotec, O Goulet, J Schmitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15269630     DOI： 10.1097/00005176-200408000-00016

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  10 in total

Review 1.  Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature.

Authors:  V Wiegering; H Morbach; A Dick; H J Girschick
Journal:  Rheumatol Int       Date:  2009-06-09       Impact factor: 2.631

Review 2.  The safety profile of biologic therapies for juvenile idiopathic arthritis.

Authors:  Philip J Hashkes; Yosef Uziel; Ronald M Laxer
Journal:  Nat Rev Rheumatol       Date:  2010-08-31       Impact factor: 20.543

Review 3.  Colitis associated with biological agents.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

4.  Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumatoid arthritis.

Authors:  Asha Krishnan; Derrick J Stobaugh; Parakkal Deepak
Journal:  Rheumatol Int       Date:  2014-09-17       Impact factor: 2.631

5.  A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).

Authors:  Pierre Quartier; Florence Allantaz; Rolando Cimaz; Pascal Pillet; Claude Messiaen; Christophe Bardin; Xavier Bossuyt; Anne Boutten; Jacques Bienvenu; Agnes Duquesne; Olivier Richer; Damien Chaussabel; Agnes Mogenet; Jacques Banchereau; Jean-Marc Treluyer; Paul Landais; Virginia Pascual
Journal:  Ann Rheum Dis       Date:  2010-12-20       Impact factor: 19.103

6.  Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis.

Authors:  Boris Hügle; Fabian Speth; Johannes-Peter Haas
Journal:  Pediatr Rheumatol Online J       Date:  2017-03-14       Impact factor: 3.054

Review 7.  Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature.

Authors:  Weixun Zhou; Yan Huang; Jinping Lai; Jun Lu; Michael Feely; Xiuli Liu
Journal:  Gastroenterology Res       Date:  2018-05-31

8.  Challenges in the management of juvenile idiopathic arthritis with etanercept.

Authors:  Clare E Pain; Liza J McCann
Journal:  Biologics       Date:  2009-07-13

9.  The changing face of spondyloarthropathies under TNF α blockade.

Authors:  Ori Elkayam; Irena Litinsky; David Levartovsky; Dan Caspi
Journal:  Open Rheumatol J       Date:  2008-11-14

10.  Development of crohn's disease following treatment for juvenile idiopathic arthritis in a nigerian child: Case report and review of literature.

Authors:  Oluwafunmilayo Funke Adeniyi; Uyi Ima-Edomwonyi; A Emuobor Odeghe; I Vincent Onyekwelu
Journal:  Ann Afr Med       Date:  2019 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.